MX2015007459A - Method for generating immunization vectors for accelerating the immune response. - Google Patents

Method for generating immunization vectors for accelerating the immune response.

Info

Publication number
MX2015007459A
MX2015007459A MX2015007459A MX2015007459A MX2015007459A MX 2015007459 A MX2015007459 A MX 2015007459A MX 2015007459 A MX2015007459 A MX 2015007459A MX 2015007459 A MX2015007459 A MX 2015007459A MX 2015007459 A MX2015007459 A MX 2015007459A
Authority
MX
Mexico
Prior art keywords
generating
accelerating
immune response
vectors
immunization vectors
Prior art date
Application number
MX2015007459A
Other languages
Spanish (es)
Inventor
Fedorovish Licea Navarro Alexei
Sujey Beltran Lopez Adriana
Sanchez Castrejon Edna
Original Assignee
Centro De Investig Cientifica Y De Educacion Superior De Ensenada Baja California (Cicese)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Investig Cientifica Y De Educacion Superior De Ensenada Baja California (Cicese) filed Critical Centro De Investig Cientifica Y De Educacion Superior De Ensenada Baja California (Cicese)
Priority to MX2015007459A priority Critical patent/MX2015007459A/en
Publication of MX2015007459A publication Critical patent/MX2015007459A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Described is a method for generating immunization vectors from immune libraries generated in the Heterodontus francisci shark by means of the administration of dendritic cells of mammals or any other isolated and purified antigen for generating IgG neutralizing antibodies against specific toxins linked to those vectors.
MX2015007459A 2015-06-04 2015-06-04 Method for generating immunization vectors for accelerating the immune response. MX2015007459A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2015007459A MX2015007459A (en) 2015-06-04 2015-06-04 Method for generating immunization vectors for accelerating the immune response.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2015007459A MX2015007459A (en) 2015-06-04 2015-06-04 Method for generating immunization vectors for accelerating the immune response.

Publications (1)

Publication Number Publication Date
MX2015007459A true MX2015007459A (en) 2016-12-05

Family

ID=58159918

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007459A MX2015007459A (en) 2015-06-04 2015-06-04 Method for generating immunization vectors for accelerating the immune response.

Country Status (1)

Country Link
MX (1) MX2015007459A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109943572A (en) * 2017-11-07 2019-06-28 香港城市大学 The method for producing antibody fragment

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109943572A (en) * 2017-11-07 2019-06-28 香港城市大学 The method for producing antibody fragment
US11180544B2 (en) * 2017-11-07 2021-11-23 City University Of Hong Kong Method of producing antibody fragment
CN109943572B (en) * 2017-11-07 2022-06-03 香港城市大学 Method for producing antibody fragment

Similar Documents

Publication Publication Date Title
EA201992469A1 (en) ANTIGEN SPECIFIC IMMUNE EFFECTIVE CELLS
MX2017012429A (en) Antibodies directed against t cell immunoglobulin and mucin protein 3 (tim-3).
ZA202209045B (en) Novel anti-lam and anti-pim6/lam monoclonal antibodies for diagnosis and treatment of mycobacterium tuberculosis infections
PH12018502478A1 (en) Bispecific binding proteins binding an immunomodulatory protein and a tumor antigen
PH12017500819A1 (en) Cd3/cd38 t cell retargeting hetero-dimeric immunoglobulins and methods of their production
AU2018253589A1 (en) Antibodies, pharmaceutical compositions and uses thereof
MX2023001791A (en) Antibodies directed against interleukin 36 receptor (il-36r).
NZ747857A (en) Methods for breaking immunological tolerance using multiple guide rnas
AR110321A1 (en) ANTITAU ANTIBODIES AND METHODS OF USE
AR104718A1 (en) RECEIVERS OF ANTI-GD3 SPECIFIC CHEMICAL ANTIGENS FOR IMMUNOTHERAPIES AGAINST CANCER
MX2018014979A (en) Anti hla-g specific antibodies.
MX2018008934A (en) Anti-ror1 antibodies, ror1 x cd3 bispecific antibodies, and methods of using the same.
PE20240365A1 (en) ANTI-C5 ANTIBODIES AND METHODS OF USE
BR112016022369A2 (en) cd33-specific chimeric antigen receptors for cancer immunotherapy
PE20211291A1 (en) ANTI-OX40 ANTIBODIES AND METHODS OF USE
WO2015112749A3 (en) Methods and compositions for antibody and antibody-loaded dendritic cell mediated therapy
AU2015287227A8 (en) Immune-stimulating monoclonal antibodies against human interleukin-2
MX2017003691A (en) Methods of treating systemic lupus erythematosus using a domain antibody directed against cd28.
JOP20190246A1 (en) Monoclonal antibody to pd-l1
BR112017009790A2 (en) anti-ang2 antibodies and methods of use
MX2020004094A (en) Methods of administering chimeric antigen receptor immunotherapy.
PH12021550521A1 (en) Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof
MX2015007459A (en) Method for generating immunization vectors for accelerating the immune response.
MX2019014291A (en) Treatment method.
CL2017001471A1 (en) New protein structure produced by an effective antibody used for immunization